Following Women With High Blood Pressure After Childbirth in Switzerland
Follows women with high blood pressure after childbirth to track their health over time.
Key facts
- Who runs it
- University Hospital, Basel, Switzerland
- Where
- Basel, SwitzerlandSee the site
- Trial code
- Registry title
- Swiss Postpartum Hypertension Cohort
- Status
- Recruiting
- People taking part
- 480 people, planned
- Started
- 4 Jun 2020
- Expected to end
- May 2030
- Type of study
- Observational
- Treatments tested
- Data collection for parameters of organ damage (cardiac and renal blood markers)
- Data collection for blood pressure (BP)
- Home-based blood pressure management (substudy)
- Biomarker Profiles (substudy)
- Data collection on patient reported outcomes
- Record updated
- 28 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women over 18 who have high blood pressure after giving birth, or who had high blood pressure during pregnancy or before it. Researchers follow them over time.
- Age
- 18 years and older
- Sex
- Women only
- Disease stage
- High blood pressure within the first 14 days after delivery (systolic 140 or higher and/or diastolic 90 mmHg or higher, or taking blood pressure medicine). Women with high blood pressure disorders of pregnancy, pre-existing high blood pressure, or on blood pressure medicine can also join.
Main reasons for not taking part
- Delivery more than 14 days ago
- No consent to take part
- Language barriers
- Lack of general understanding
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- all women with hypertensive disorders of pregnancy
- postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery)
- women with preexisting hypertension or
- women on antihypertensive medication
Who cannot take part
- delivery > 14 days
- lack of consent to participate in the study, language barriers or lack of general understanding
Where in Switzerland
- Medical Outpatient Department and Hypertension Clinic, University Hospital BaselBasel, SwitzerlandContact: Thenral Socrates, Dr. med.Taking people
About the trial
What the trial wants to find out
This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk.
Read full original descriptionShow less
Current disease management strategies will be evaluated.
Treatments tested
- Data collection for parameters of organ damage (cardiac and renal blood markers)
- Data collection for blood pressure (BP)
- Home-based blood pressure management (substudy)
- Biomarker Profiles (substudy)
- Data collection on patient reported outcomes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Swiss Postpartum Hypertension Cohort (Swiss-PPHT)
- Plain-language title
- Following Women With High Blood Pressure After Childbirth in SwitzerlandGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 May 2025